Department of Physiotherapy and Occupational Therapy, Aalborg University Hospital, Denmark and Public Health and Epidemiology Group, Department of Health, Science and Technology, Aalborg University, Aalborg, Denmark.
Department of Public Health, University of Southern Denmark Odense, Denmark.
PLoS One. 2022 Oct 31;17(10):e0276955. doi: 10.1371/journal.pone.0276955. eCollection 2022.
BACKGROUND: Redundancy is an unethical, unscientific, and costly challenge in clinical health research. There is a high risk of redundancy when existing evidence is not used to justify the research question when a new study is initiated. Therefore, the aim of this study was to synthesize meta-research studies evaluating if and how authors of clinical health research studies use systematic reviews when initiating a new study. METHODS: Seven electronic bibliographic databases were searched (final search June 2021). Meta-research studies assessing the use of systematic reviews when justifying new clinical health studies were included. Screening and data extraction were performed by two reviewers independently. The primary outcome was defined as the percentage of original studies within the included meta-research studies using systematic reviews of previous studies to justify a new study. Results were synthesized narratively and quantitatively using a random-effects meta-analysis. The protocol has been registered in Open Science Framework (https://osf.io/nw7ch/). RESULTS: Twenty-one meta-research studies were included, representing 3,621 original studies or protocols. Nineteen of the 21 studies were included in the meta-analysis. The included studies represented different disciplines and exhibited wide variability both in how the use of previous systematic reviews was assessed, and in how this was reported. The use of systematic reviews to justify new studies varied from 16% to 87%. The mean percentage of original studies using systematic reviews to justify their study was 42% (95% CI: 36% to 48%). CONCLUSION: Justification of new studies in clinical health research using systematic reviews is highly variable, and fewer than half of new clinical studies in health science were justified using a systematic review. Research redundancy is a challenge for clinical health researchers, as well as for funders, ethics committees, and journals.
背景:冗余是临床健康研究中不道德、不科学且代价高昂的挑战。当启动新研究时,如果没有利用现有证据来论证研究问题,就存在很高的冗余风险。因此,本研究旨在综合评价元研究,评估临床健康研究的作者在启动新研究时是否以及如何使用系统评价。
方法:共检索了 7 个电子文献数据库(最终检索日期为 2021 年 6 月)。纳入了评估使用系统评价来论证新临床健康研究的元研究。两名评审员独立进行筛选和数据提取。主要结局定义为纳入的元研究中使用先前研究系统评价来论证新研究的原始研究的百分比。使用随机效应荟萃分析对结果进行定性和定量综合。该方案已在开放科学框架(https://osf.io/nw7ch/)上注册。
结果:共纳入 21 项元研究,代表 3621 项原始研究或方案。21 项研究中有 19 项被纳入荟萃分析。纳入的研究代表了不同的学科,在评估和报告先前系统评价的使用方面存在很大的差异。使用系统评价来论证新研究的比例从 16%到 87%不等。使用系统评价来论证其研究的原始研究的平均百分比为 42%(95%CI:36%至 48%)。
结论:临床健康研究中使用系统评价来论证新研究的情况差异很大,不到一半的健康科学新临床研究是用系统评价来论证的。研究冗余是临床健康研究人员以及资助者、伦理委员会和期刊面临的挑战。
Cochrane Database Syst Rev. 2014-10-1
Early Hum Dev. 2020-11
BMC Med Res Methodol. 2018-1-11
Res Social Adm Pharm. 2024-4
J Osteopath Med. 2021-5-21
J Clin Epidemiol. 2021-1
Eur J Obstet Gynecol Reprod Biol. 2020-9
J Evid Based Med. 2020-8
J Clin Epidemiol. 2020-11